DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Acetylcysteine Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.
According to the analysis, the sales value of Acetylcysteine has grown rapidly from 2016 to 2019 in China, with the highest Year-on-Year growth rate of 47.93% in 2019.
In 2020, the sales value of Acetylcysteine increased by about 8.84% to CNY 1.016 billion in China. The main reason is that the Covid-19 epidemic has affected the hospital’s overall diagnosis and treatment business, resulting in a decline in its growth rate. The CAGR of Acetylcysteine’s sales value in the Chinese market from 2016 to 2020 is 24.74%.
Acetylcysteine, also known as N-acetylcysteine (NAC), is a medication that is used to treat paracetamol (acetaminophen) overdose, and to loosen thick mucus in individuals with chronic bronchopulmonary disorders like pneumonia and bronchitis. Acetylcysteine was initially patented in 1960 and came into medical use in 1968.
Its product, FLUIMUCIL was developed by Zambon Italia Srl. Acetylcysteine was approved in China in 2002. By the half past of 2021, in addition to Zambon Italia Srl, there are more than 10 generic drug manufacturers in the Chinese Acetylcysteine market, such as Hangzhou Minsheng Pharmaceutical Co. ,Ltd., Hainan Star Pharmaceutical Co., Ltd. and Ruiyang Pharmaceutical Co., Ltd.
The analyst predicts that the sales of Acetylcysteine in the Chinese market will have a restorative growth from 2021 to 2025 with the effective alleviation of the Covid-19 epidemic. In addition, Kangyuan Pharmaceutical submitted an application of Acetylcysteine solution for inhalation for marketing authorization on March 16 2021.
It is expected that the price of acetylcysteine will decrease with the addition of new manufacturers. There is room for growth in both sales volume and sales.
Topics Covered:
- The impact of COVID-19 on China’s Acetylcysteine market
- Sales value of China’s Acetylcysteine 2016-2020
- Competitive landscape of China’s Acetylcysteine market
- Prices of Acetylcysteine in China
- Prices of Acetylcysteine in China by regions and manufacturers
- Analysis of factors affecting the development of China’s Acetylcysteine market
- Prospect of China’s Acetylcysteine market from 2021 to 2025
Key Topics Covered:
1 Relevant Concepts of Acetylcysteine
1.1 Indications for Acetylcysteine
1.2 Development of Acetylcysteine in China
1.3 Governmental Approval of Acetylcysteine in China
1.4 The Impact of COVID-19 on Acetylcysteine sales in China
2 Sales of Acetylcysteine in China, 2016-2020
2.1 Sales Value of Acetylcysteine
2.1.1 Overall Sales Value
2.1.2 Sales Value by Regions
2.2 Sales Volume of Acetylcysteine
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Regions
2.3 Sales of Acetylcysteine by Dosage Form in China, 2016-2020
2.3.1 Injection
2.3.2 Granules
2.3.3 Tablets
2.3.4 Capsules
2.3.5 Effervescent Tablets
2.3.6 Solution for Inhalation
3 Analysis of Major Acetylcysteine Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Acetylcysteine Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Hangzhou Minsheng Pharmaceutical Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Asixintai (Hangzhou Minsheng Pharmaceutical Co., Ltd.’s Acetylcysteine) in China
3.3 Zambon Italia Srl
3.3.1 Enterprise Profile
3.3.2 Sales of FLUIMUCIL (Zambon Italia Srl’s Acetylcysteine) in China
3.4 Hainan Star Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Boqing (Hainan Star Pharmaceutical Co., Ltd.’s Acetylcysteine) in China
3.5 Ruiyang Pharmaceutical Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Kebining (Ruiyang Pharmaceutical Co., Ltd.’s Acetylcysteine) in China
3.6 Hainan Zambon Pharmaceutical Co., Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of FLUIMUCIL (Hainan Zambon Pharmaceutical Co., Ltd.’s Acetylcysteine) in China
4 Prices of Acetylcysteine for Different Manufacturers in China, 2020
4.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. (Asixintai)
4.2 Zambon Italia Srl (FLUIMUCIL)
4.3 Hainan Star Pharmaceutical Co., Ltd. (Boqing)
4.4 Ruiyang Pharmaceutical Co., Ltd. (Kebining)
4.5 Hainan Zambon Pharmaceutical Co., Ltd. (FLUIMUCIL)
5 Prospect of Chinese Acetylcysteine Market, 2021-2025
5.1 Influential Factors of Chinese Acetylcysteine Market Development
5.1.1 The Impact of COVID-19 on Chinese Acetylcysteine Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
For more information about this report visit https://www.researchandmarkets.com/r/rd449
The content is by Business Wire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.
